{"id":"W2776657901","doi":"10.1136/rmdopen-2017-000592","title":"Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2","year":2017,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"Novartis Pharma","keywords":"Medicine; Ankylosing spondylitis; Secukinumab; Physical therapy; Spondylitis; Signs and symptoms; Measure (data warehouse); Internal medicine; Arthritis; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006873378,0.0001692937,0.000390477,0.00002963986,0.0004847955,0.0002138756,0.0003131762,0.00005731593,0.00003036453],"category_scores_gemma":[0.0003915393,0.00008695392,0.00004336892,0.00008416148,0.0001804894,0.0003134301,0.0001958547,0.00014095,0.000001110117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007507482,"about_ca_system_score_gemma":0.0001079583,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01184518,"about_ca_topic_score_gemma":0.00177761,"domain_scores_codex":[0.9986895,0.0001671033,0.0003058378,0.0003424541,0.0002780191,0.0002170506],"domain_scores_gemma":[0.9985983,0.0001952742,0.0003597289,0.0006610152,0.0001427136,0.00004298279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8247023,0.002075779,0.008897081,0.00008606323,0.001771072,0.0006487225,0.01511444,7.179812e-7,0.005281979,0.0007406723,0.0008933191,0.1397879],"study_design_scores_gemma":[0.8097324,0.01400574,0.1466687,0.001334182,0.0007637028,0.00001655597,0.02044273,0.00002212166,0.003776046,0.0008163175,0.002129593,0.0002919727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917949,0.0001698617,0.000003048314,0.001717501,0.00007537968,0.004016487,0.0007384677,0.000007489823,0.001476882],"genre_scores_gemma":[0.9989706,0.00006618159,0.00006578227,0.0001122764,0.00009084481,0.0001608776,0.0002630875,0.00001616051,0.0002541507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1394959,"threshold_uncertainty_score":0.994735,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03354987507514975,"score_gpt":0.3117454080993967,"score_spread":0.2781955330242469,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}